23.02.2013 Views

The European Pharmaceutical Wholesale Industry: - phagro

The European Pharmaceutical Wholesale Industry: - phagro

The European Pharmaceutical Wholesale Industry: - phagro

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

41<br />

<strong>The</strong> <strong>European</strong> <strong>Pharmaceutical</strong> <strong>Wholesale</strong> <strong>Industry</strong><br />

On average, medicines are ordered from manufacturers from 2.5 times a month in<br />

the UK up to 4.5 times in the NL. In case of special need order-frequencies for<br />

certain products are, of course, higher. In some northern <strong>European</strong> countries, order<br />

frequencies of some companies exceed the average up to 3 times.<br />

<strong>The</strong> relationship between the pharmaceutical industry and wholesalers is affected<br />

by the provision of services by the latter creating added value for manufacturers.<br />

<strong>The</strong> most important of these services are related to marketing activities and promotional<br />

support, the provision of sales and inventory statistics but also assistance<br />

at product launches or offering logistics services of clinical trials. As these<br />

services form an integrative part in the relationship with manufacturers, it is<br />

widely expected within the industry that the importance of such services is likely<br />

to rise considerably in the near future as competition between wholesalers, but<br />

also between pharmaceutical companies, is speeding up. In times of increasing<br />

direct distribution and a strained relationship between manufacturers and wholesalers<br />

in the debate on supply quota systems, services more and more become<br />

the crucial competitive factor in pharmaceutical wholesaling.<br />

6.3.2 Warehousing<br />

Items on stock ranged from 6,000 to more than 90,000 depending on the size of<br />

the market and the number of pharmaceuticals 12 authorized to be marketed. On a<br />

<strong>European</strong> average, wholesaler stock 29,151 different items, of which 49% are<br />

pharmaceuticals. <strong>The</strong> share of medicines within the product range differs considerably<br />

from country to country, depending on the number of pharmaceuticals allowed<br />

for marketing.<br />

Figure 34: <strong>Pharmaceutical</strong>s and non-<strong>Pharmaceutical</strong> Products on Stock<br />

(in thousand), 2004<br />

100<br />

90<br />

80<br />

70<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

90<br />

54<br />

76<br />

25<br />

50<br />

33<br />

33<br />

GER IT AUT NL FR UK ESP<br />

IPF Institute for Pharmaeconomic Research<br />

21<br />

28<br />

14<br />

Products on stock <strong>Pharmaceutical</strong>s on stock<br />

Source: IPF research<br />

12<br />

<strong>The</strong> term pharmaceuticals denotes all Rx and OTC products. Para-pharmaceuticals are<br />

classified as non-pharmaceuticals.<br />

18<br />

12<br />

28<br />

10

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!